BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml

7680006370036 Pharmacode 1108219 CH-637 J07AJ52 08.08.
BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml
BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml
BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml
1 / 3
google

Details

GTIN
7680006370036
Pharmacode
1108219
Product number
0063701
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
toxoidum diphtheriae ≥ 2 U.I., toxoidum tetani ≥ 20 U.I., toxoidum pertussis 8 µg, haemagglutininum filamentosum 8 µg, pertactinum 2.5 µg, aluminium ut aluminii phosphas et aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, polysorbatum 80, formaldehydum.

Articles (1)

Boostrix, Injektionssuspension
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/06/2025
Professional SmPC
Français
26/06/2025
Professional SmPC
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
toxoidum diphtheriae
- Substance Wirkstoff (Principe actif)
toxoidum tetani
- Substance Wirkstoff (Principe actif)
toxoidum pertussis
8.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum filamentosum
8.0 UG Substance Wirkstoff (Principe actif)
pertactinum
2.5 UG Substance Wirkstoff (Principe actif)
aluminium
- Substance HNIDK
aluminii phosphas
- Substance HNIDK
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
1.8 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK
polysorbatum 80
- Substance RESI
formaldehydum
- Substance RESI

Reimbursement information

Public price
CHF 35.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2001

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
637
Drug name
Boostrix, Injektionssuspension
Galenic form
SUPA
ATC Code
J07AJ52
Authorization status
Z
Dispensation category
B
First authorization
10/08/2000
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Auffrischimpfung gegen Diphtherie, Tetanus und Pertussis, ab dem vollendeten 4. Lebensjahr

Packaging details

Description (FR)
BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml
Description (DE)
BOOSTRIX Inj Susp (n Fertspr) Fertspr 0.5 ml
Market launch
10/08/2000
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

BOOSTRIX susp inj (n ser pré) 10 ser pré 0.5 ml
10 FESP
View
Buy us a coffee Explore the data